Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Rezolute, Inc.(RZLT) | 1,603,986 | 1,986,818 | +382,832 | $7.15M | $18.68M | 81.70% | +$11.52M |
| SPDR Gold SharesGOLD SHS(GLD) | 4,952 | 7,286 | +2,334 | $1.51M | $2.59M | 11.33% | +$1.08M |
| Berkshire Hathaway Inc DelCL B | 632 | 651 | +19 | $307.0K | $327.5K | 1.43% | +$20.4K |
| Mind Medicine Mindmed Inc | 34,073 | 27,011 | -7,062 | $221.1K | $318.5K | 1.39% | +$97.3K |
| Enliven Therapeutics Inc | 13,097 | 13,097 | 0 | $262.7K | $268.1K | 1.17% | +$5.4K |
| Compass Therapeutics, Inc.(CMPX) | 43,465 | 53,503 | +10,038 | $113.0K | $187.3K | 0.82% | +$74.3K |
| Bicara Therapeutics Inc | 10,941 | 10,941 | 0 | $101.6K | $172.8K | 0.76% | +$71.1K |
| Kyverna Therapeutics, Inc.(KYTX) | 22,981 | 22,981 | 0 | $70.6K | $137.9K | 0.60% | +$67.3K |
| Lexeo Therapeutics, Inc.(LXEO) | 17,332 | 17,332 | 0 | $69.7K | $115.1K | 0.50% | +$45.4K |
| Inhibikase Therapeutics, Inc.(IKT) | 16,393 | 16,393 | 0 | $32.0K | $26.6K | 0.12% | -$5.4K |
| SAB Biotherapeutics, Inc.(SABS) | 0 | 10,935 | +10,935 | $0 | $22.0K | 0.10% | +$22.0K |
| Context Therapeutics Inc.(CNTX) | 18,403 | 18,403 | 0 | $12.1K | $17.8K | 0.08% | +$5.8K |